Paper235486
Red cell abnormalities associated with sulphasalazine maintenance therapy for ulcerative colitis.
Pounder RE and 3 others. Gut, 1975. Cited by 52 papers, by iCite.
Cite this record
ConductScience Library. Red cell abnormalities associated with sulphasalazine maintenance therapy for ulcerative colitis. Papers, record 235486. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/235486
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Red cell abnormalities associated with sulphasalazine maintenance therapy for ulcerative colitis.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Colitis, Ulcerative | Major topic |
| Erythrocytes, Abnormal | Major topic |
| Hematologic Diseases | Major topic |
| Sulfasalazine | Major topic |
| Anemia, Hemolytic | |
| Erythrocyte Count | |
| Heinz Bodies | |
| Hematocrit | |
| Humans | |
| Methemoglobinemia | |
| Pyridines | |
| Reticulocytes |
Source PubMed
References15
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4145285 | Determination of sulphapyridine and its metabolites in biological materials after administration of salicylazosulphapyridine. | Acta Pharm Suec | 1973 | https://conductscience.org/library/papers/4145285 | PubMed |
| 2 | 4148104 | Letter: Hemolytic anemia as adverse reaction to salicylazosulfapyridine. | N Engl J Med | 1973 | https://conductscience.org/library/papers/4148104 | PubMed |
| 3 | 4146729 | Adverse reactions during salicylazosulfapyridine therapy and the relation with drug metabolism and acetylator phenotype. | N Engl J Med | 1973 | https://conductscience.org/library/papers/4146729 | PubMed |
| 4 | 4147555 | The metabolism of salicylazosulphapyridine in ulcerative colitis. I. The relationship between metabolites and the response to treatment in inpatients. | Gut | 1973 | https://conductscience.org/library/papers/4147555 | PubMed |
| 5 | 4150435 | A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphazalazine (Salazopyrin). | Gut | 1973 | https://conductscience.org/library/papers/4150435 | PubMed |
| 6 | 14050794 | THE OCCURRENCE OF HEINZ BODIES DURING AZULFIDINE TREATMENT OF ULCERATIVE COLITIS. | Gastroenterologia | 1963 | https://conductscience.org/library/papers/14050794 | PubMed |
| 7 | 14238045 | PREDNISONE AS MAINTENANCE TREATMENT FOR ULCERATIVE COLITIS IN REMISSION. | Lancet | 1965 | https://conductscience.org/library/papers/14238045 | PubMed |
| 8 | 14218553 | CONTROLLED TRIAL OF SULPHASALAZINE IN THE TREATMENT OF ULCERATIVE COLITIS. | Gut | 1964 | https://conductscience.org/library/papers/14218553 | PubMed |
| 9 | 14197149 | HEMOLYTIC ANEMIA SECONDARY TO SALICYLAZOSULFAPYRIDINE THERAPY. | JAMA | 1964 | https://conductscience.org/library/papers/14197149 | PubMed |
| 10 | 13967788 | Drug-associated blood dyscrasias. Recent additions to the Registry. | JAMA | 1963 | https://conductscience.org/library/papers/13967788 | PubMed |
| 12 | 4136052 | Hyposplenism in ulcerative colitis. | Lancet | 1974 | https://conductscience.org/library/papers/4136052 | PubMed |
| 13 | 4137782 | Letter: Hyposplenism in ulcerative colitis. | Lancet | 1974 | https://conductscience.org/library/papers/4137782 | PubMed |
| 14 | 4402420 | Acetylator phenotype and adverse effects of sulphasalazine in healthy subjects. | Gut | 1972 | https://conductscience.org/library/papers/4402420 | PubMed |
| 15 | 4402886 | Absorption, metabolism, and excretion of salicylazosulfapyridine in man. | Clin Pharmacol Ther | 1972 | https://conductscience.org/library/papers/4402886 | PubMed |
| 16 | 4386139 | Ulcerative colitis and erythrocyte G6PD deficiency. Salicylazosulfapyridine-provoked hemolysis. | JAMA | 1968 | https://conductscience.org/library/papers/4386139 | PubMed |
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 52 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 31824960 | The Role of Iron Regulation in Immunometabolism and Immune-Related Disease. | Front Mol Biosci | 2019 | https://conductscience.org/library/papers/31824960 | PubMed |
| 7945999 | The role of active metabolites in drug toxicity. | Drug Saf | 1994 | https://conductscience.org/library/papers/7945999 | PubMed |
| 7851193 | Safety and efficacy of controlled-release mesalamine for maintenance of remission in ulcerative colitis. Pentasa UC Maintenance Study Group. | Dig Dis Sci | 1995 | https://conductscience.org/library/papers/7851193 | PubMed |
| 6136396 | Sulfasalazine. Adverse effects and desensitization. | Dig Dis Sci | 1983 | https://conductscience.org/library/papers/6136396 | PubMed |
| 6114899 | Role of sulphasalazine in the aetiology of folate deficiency in ulcerative colitis. | Gut | 1981 | https://conductscience.org/library/papers/6114899 | PubMed |
| 6105118 | Optimum dose of sulphasalazine for maintenance treatment in ulcerative colitis. | Gut | 1980 | https://conductscience.org/library/papers/6105118 | PubMed |
| 2877847 | Sulphasalazine: a review of 40 years' experience. | Drugs | 1986 | https://conductscience.org/library/papers/2877847 | PubMed |
| 2874103 | Sulphasalazine associated pancytopenia may be caused by acute folate deficiency. | Gut | 1986 | https://conductscience.org/library/papers/2874103 | PubMed |
| 2872667 | Megaloblastic anaemia due to sulphasalazine responding to drug withdrawal alone. | Postgrad Med J | 1986 | https://conductscience.org/library/papers/2872667 | PubMed |
| 2563951 | Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. | BMJ | 1989 | https://conductscience.org/library/papers/2563951 | PubMed |
| 1685664 | Direct and metabolism-dependent toxicity of sulphasalazine and its principal metabolites towards human erythrocytes and leucocytes. | Br J Clin Pharmacol | 1991 | https://conductscience.org/library/papers/1685664 | PubMed |
| 456215 | Autoimmune hemolytic anemia in ulcerative colitis: report of three cases, review of the literature, and evaluation of modes of therapy. | Dig Dis Sci | 1979 | https://conductscience.org/library/papers/456215 | PubMed |
| 15752 | Clinical pharmacokinetics of sulphasalazine. | Clin Pharmacokinet | 1976 | https://conductscience.org/library/papers/15752 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/235486
GET https://conductscience.org/api/papers/v1/235486/authors